CFDE Data Portal | Search PHOX2B-AS1

	Label	Description
	PHOX2B-AS1 Gene (Entity type)	ENSG00000250467 - PHOX2B antisense RNA 1
	GSE187006 3 V 2 VALPROIC ACID HUMAN UP Gene Set (Entity type)	A Gene Set from LINCS
	GSE100148 EZH2 inhibition 10 v 5 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE216273 GSE216292 palbociclib 0 v 7 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE212312 FBXW7 knockout Reh 1 v 3 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE104526 p53 LSD1 inhibition 1 v 0 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE182157 AS3MT knockout SH-SY5Y 3 v 0 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE203522 dopamine SH-SY5Y 2 v 1 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE130401 6 V 0 TRAMETINIB HUMAN DN Gene Set (Entity type)	A Gene Set from LINCS
	GSE216273,GSE216292 0 V 7 PALBOCICLIB HUMAN UP Gene Set (Entity type)	A Gene Set from LINCS

PHOX2B-AS1

ENSG00000250467 - PHOX2B antisense RNA 1

GSE187006 3 V 2 VALPROIC ACID HUMAN UP

A Gene Set from LINCS

GSE100148 EZH2 inhibition 10 v 5 human dn

A Gene Set from LINCS

GSE216273 GSE216292 palbociclib 0 v 7 human up

A Gene Set from LINCS

GSE212312 FBXW7 knockout Reh 1 v 3 human up

A Gene Set from LINCS

GSE104526 p53 LSD1 inhibition 1 v 0 human dn

A Gene Set from LINCS

GSE182157 AS3MT knockout SH-SY5Y 3 v 0 human up

A Gene Set from LINCS

GSE203522 dopamine SH-SY5Y 2 v 1 human up

A Gene Set from LINCS

GSE130401 6 V 0 TRAMETINIB HUMAN DN

A Gene Set from LINCS

GSE216273,GSE216292 0 V 7 PALBOCICLIB HUMAN UP

A Gene Set from LINCS

DISPLAY PER PAGE

@CFDE Workbench 2026

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2026

This repository is under review for potential modification in compliance with Administration directives.